The 2010 ESPEN Sir David Cuthbertson Lecture: New and old proteins: Clinical implications

Clinical Nutrition

Volumn 32, Issue 5, 2013, Pages 728-736

  McCoy, Rozalina G ^a   Nair, K Sreekumaran ^a  

^a Mayo Clinic College of Medicine   (United States)

Author keywords

Aging; Caloric restriction; Proteomics; Senescence

Indexed keywords

APOLIPOPROTEIN A1; INSULIN; REACTIVE OXYGEN METABOLITE;

AEROBIC EXERCISE; AGING; ARTICLE; CALORIC RESTRICTION; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERINSULINEMIA; INSULIN DEFICIENCY; INSULIN METABOLISM; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; PROTEOMICS; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENESCENCE;

(13)C(6)-PHE; 2-DIMENSIONAL GEL ELECTROPHORESIS; 2D-GE; AGING; APOA-1; APOLIPOPROTEIN A-1; CALORIC RESTRICTION; IE; ISOTOPIC ENRICHMENT; MASS SPECTROMETRY; MOLAR PERCENT EXCESS; MPE; MS; POST-TRANSLATIONAL MODIFICATION; PROTEOMICS; PTM; REACTIVE OXYGEN SPECIES; ROS; SENESCENCE; [RING-(13)C(6)]-PHENYLALANINE;

AGING; ANIMALS; CALORIC RESTRICTION; EUROPE; EXERCISE; HUMANS; INSULIN; METABOLIC DISEASES; MUSCLE PROTEINS; MUSCLE, SKELETAL; OXIDATIVE STRESS; PROTEIN STABILITY; PROTEOME; PROTEOMICS; SOCIETIES, SCIENTIFIC; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84883559604     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2012.12.015     Document Type: Article

References (95)

1. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G., et al. The sequence of the human genome. Science 2001, 291:1304-1351.
2. Human genome sequencing C. Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
3. Lander E.S., Linton L.M., Birren B., Nusbaum C., Zody M.C., Baldwin J., et al. Initial sequencing and analysis of the human genome. Nature 2001, 409:860-921.
4. Stolerman E.S., Florez J.C. Genomics of type 2 diabetes mellitus: implications for the clinician. Nat Rev Endocrinol 2009, 5:429-436.
5. Nair K.S., Jaleel A., Asmann Y.W., Short K.R., Raghavakaimal S. Proteomic research: potential opportunities for clinical and physiological investigators. Am J Physiol Endocrinol Metab 2004, 286:E863-E874.
6. Jaleel A., Nehra V., Persson X.M.T., Boirie Y., Bigelow M., Nair K.S. Invivo measurement of synthesis rate of multiple plasma proteins in humans. Am J Physiol Endocrinol Metab 2006, 291:E190-E197.
7. Jaleel A., Short K.R., Asmann Y.W., Klaus K.A., Morse D.M., Ford G.C., et al. Invivo measurement of synthesis rate of individual skeletal muscle mitochondrial proteins. Am J Physiol Endocrinol Metab 2008, 295:E1255-E1268.
8. Henderson G.C., Dhatariya K., Ford G.C., Klaus K.A., Basu R., Rizza R.A., et al. Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. FASEB J 2009, 23:631-641.
9. Nair K.S., Ford G.C., Ekberg K., Fernqvist-Forbes E., Wahren J. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. JClin Invest 1995, 95:2926-2937.
10. Short K.R., Meek S.E., Moller N., Ekberg K., Nair K.S. Whole body protein kinetics using Phe and Tyr tracers: an evaluation of the accuracy of approximated flux values. Am J Physiol 1999, 276:E1194-E1200.
11. Thompson G.N., Pacy P.J., Merritt H., Ford G.C., Read M.A., Cheng K.N., et al. Rapid measurement of whole body and forearm protein turnover using a [2H5] phenylalanine model. Am J Physiol 1989, 256:E631-E639.
12. Barrett E.J., Revkin J.H., Young L.H., Zaret B.L., Jacob R., Gelfand R.A. An isotopic method for measurement of muscle protein synthesis and degradation invivo. Biochem J 1987, 245:223-228.
13. Yen H.C., Xu Q., Chou D.M., Zhao Z., Elledge S.J. Global protein stability profiling in mammalian cells. Science 2008, 322:918-923.
14. Doherty M.K., Hammond D.E., Clague M.J., Gaskell S.J., Beynon R.J. Turnover of the human proteome: determination of protein intracellular stability by dynamic SILAC. JProteome Res 2009, 8:104-112.
15. Yewdell J.W., Lacsina J.R., Rechsteiner M.C., Nicchitta C.V. Out with the old, in with the new? Comparing methods for measuring protein degradation. Cell Biol Int 2011, 35:457-462.
16. Fu A., Nair K.S. Age effect on fibrinogen and albumin synthesis in humans. Am J Physiol 1998, 275:E1023-E1030.
17. Rattan S.I., Derventzi A., Clark B.F. Protein synthesis, posttranslational modifications, and aging. Ann N Y Acad Sci 1992, 663:48-62.
18. Parekh R.B., Rohlff C. Post-translational modification of proteins and the discovery of new medicine. Curr Opin Biotechnol 1997, 8:718-723.
19. Madian A.G., Regnier F.E. Proteomic identification of carbonylated proteins and their oxidation sites. JProteome Res 2010, 9:3766-3780.
20. Perez V.I., Buffenstein R., Masamsetti V., Leonard S., Salmon A.B., Mele J., et al. Protein stability and resistance to oxidative stress are determinants of longevity in the longest-living rodent, the naked mole-rat. Proc Natl Acad Sci U S A 2009, 106:3059-3064.
21. Stadtman E.R. Role of oxidant species in aging. Curr Med Chem 2004, 11:1105-1112.
22. Nuss J.E., Amaning J.K., Bailey C.E., DeFord J.H., Dimayuga V.L., Rabek J.P., et al. Oxidative modification and aggregation of creatine kinase from aged mouse skeletal muscle. Aging (Albany NY) 2009, 1:557-572.
23. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005, 54:1615-1625.
24. Uttara B., Singh A.V., Zamboni P., Mahajan R.T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr Neuropharmacol 2009, 7:65-74.
25. Naito Y., Takano H., Yoshikawa T. Oxidative stress-related molecules as a therapeutic target for inflammatory and allergic diseases. Curr Drug Targets Inflamm Allergy 2005, 4:511-515.
26. Victor V.M., Rocha M., Sola E., Banuls C., Garcia-Malpartida K., Hernandez-Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 2009, 15:2988-3002.
27. Valko M., Rhodes C.J., Moncol J., Izakovic M., Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 2006, 160:1-40.
28. Zhou J., Huang K. Peroxynitrite mediates muscle insulin resistance in mice via nitration of IRbeta/IRS-1 and Akt. Toxicol Appl Pharmacol 2009, 241:101-110.
29. Brock J.W., Jenkins A.J., Lyons T.J., Klein R.L., Yim E., Lopes-Virella M., et al. Increased methionine sulfoxide content of apoA-I in type 1 diabetes. JLipid Res 2008, 49:847-855.
30. Jaleel A., Henderson G.C., Madden B.J., Klaus K.A., Morse D.M., Gopala S., et al. Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes. Diabetes 2010, 59:2366-2374.
31. Geyelin H.R., Harrop G., Murray M.F., Corwin E. The use of insulin in juvenile diabetes. JMetab Res 1922, 11:767-791.
32. Geyelin H.R., Du Bois E.F. Acase of diabetes of maximum severity with marked improvement: a study of blood, urine and respiratory metabolism. JAm Med Assoc 1916, 66:1532-1534.
33. Atchley D.W., Loeb R.F., Richards D.W., Benedict E.M., Driscoll M.E. On diabetic acidosis: a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. JClin Invest 1933, 12:297-326.
34. Jaleel A., Klaus K.A., Morse D.M., Karakelides H., Ward L.E., Irving B.A., et al. Differential effects of insulin deprivation and systemic insulin treatment on plasma protein synthesis in type 1 diabetic people. Am J Physiol Endocrinol Metab 2009, 297:E889-E897.
35. Nair K.S., Garrow J.S., Ford C., Mahler R.F., Halliday D. Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 1983, 25:400-403.
36. Chow L.S., Albright R.C., Bigelow M.L., Toffolo G., Cobelli C., Nair K.S. Mechanism of insulin's anabolic effect on muscle: measurements of muscle protein synthesis and breakdown using aminoacyl-tRNA and other surrogate measures. Am J Physiol Endocrinol Metab 2006, 291:E729-E736.
37. Meek S.E., Persson M., Ford G.C., Nair K.S. Differential regulation of amino acid exchange and protein dynamics across splanchnic and skeletal muscle beds by insulin in healthy human subjects. Diabetes 1998, 47:1824-1835.
38. Nygren J., Nair K.S. Differential regulation of protein dynamics in splanchnic and skeletal muscle beds by insulin and amino acids in healthy human subjects. Diabetes 2003, 52:1377-1385.
39. Halvatsiotis P., Short K.R., Bigelow M., Nair K.S. Synthesis rate of muscle proteins, muscle functions, and amino acid kinetics in type 2 diabetes. Diabetes 2002, 51:2395-2404.
40. Luzi L., Petrides A.S., De Fronzo R.A. Different sensitivity of glucose and amino acid metabolism to insulin in NIDDM. Diabetes 1993, 42:1868-1877.
41. Staten M.A., Matthews D.E., Bier D.M. Leucine metabolism in type II diabetes mellitus. Diabetes 1986, 35:1249-1253.
42. Pereira S., Marliss E.B., Morais J.A., Chevalier S., Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 2008, 57:56-63.
43. Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res 2010, 107:1058-1070.
44. Henriksen E.J., Diamond-Stanic M.K., Marchionne E.M. Oxidative stress and the etiology of insulin resistance and type 2 diabetes. Free Radic Biol Med 2011, 51:993-999.
45. Taylor A., Davies K.J. Protein oxidation and loss of protease activity may lead to cataract formation in the aged lens. Free Radic Biol Med 1987, 3:371-377.
46. Stadtman E.R. Protein oxidation and aging. Science 1992, 257:1220-1224.
47. Rosenberger R.F. Senescence and the accumulation of abnormal proteins. Mutat Res 1991, 256:255-262.
48. Hipkiss A.R. Error-protein metabolism and ageing. Biogerontology 2009, 10:523-529.
49. Hipkiss A.R. Accumulation of altered proteins and ageing: causes and effects. Exp Gerontol 2006, 41:464-473.
50. Balagopal P., Rooyackers O., Adey D., Ades P., Nair K.S. Effect of age on synthetic rates of skeletal muscle proteins in human. JInvestig Med 1997, 45:254A.
51. Balagopal P., Rooyackers O.E., Adey D.B., Ades P.A., Nair K.S. Effects of aging on invivo synthesis of skeletal muscle myosin heavy-chain and sarcoplasmic protein in humans. Am J Physiol Endocrinol Metab 1997, 273:E790-E800.
52. Jubrias S.A., Odderson I.R., Esselman P.C., Conley K.E. Decline in isokinetic force with age: muscle cross-sectional area and specific force. Pflugers Arch 1997, 434:246-253.
53. Hughes V.A., Frontera W.R., Wood M., Evans W.J., Dallal G.E., Roubenoff R., et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. JGerontol A Biol Sci Med Sci 2001, 56:B209-B217.
54. Hazelton G.A., Lang C.A. Glutathione contents of tissues in the aging mouse. Biochem J 1980, 188:25-30.
55. Hagen T.M., Ingersoll R.T., Lykkesfeldt J., Liu J., Wehr C.M., Vinarsky V., et al. (R)-alpha-lipoic acid-supplemented oldrats have improved mitochondrial function, decreased oxidative damage, andincreased metabolic rate. FASEB J Off Publ Fed Am Societies Exp Biol 1999, 13:411-418.
56. Kim E., Lowenson J.D., MacLaren D.C., Clarke S., Young S.G. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc Natl Acad Sci U S A 1997, 94:6132-6137.
57. Nuttall S.L., Martin U., Sinclair A.J., Kendall M.J. Glutathione: in sickness and in health. Lancet 1998, 351:645-646.
58. Chondrogianni N., Gonos E.S. Proteasome dysfunction in mammalian aging: steps and factors involved. Exp Gerontol 2005, 40:931-938.
59. Martinez-Vicente M., Sovak G., Cuervo A.M. Protein degradation and aging. Exp Gerontol 2005, 40:622-633.
60. Carrard G., Bulteau A.L., Petropoulos I., Friguet B. Impairment of proteasome structure and function in aging. Int J Biochem Cell Biol 2002, 34:1461-1474.
61. Sitte N., Huber M., Grune T., Ladhoff A., Doecke W.D., Von Zglinicki T., et al. Proteasome inhibition by lipofuscin/ceroid during postmitotic aging of fibroblasts. FASEB J 2000, 14:1490-1498.
62. Brunk U.T., Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem 2002, 269:1996-2002.
63. Kruegel U., Robison B., Dange T., Kahlert G., Delaney J.R., Kotireddy S., et al. Elevated proteasome capacity extends replicative lifespan in Saccharomyces cerevisiae. PLoS Genet 2011, 7:e1002253.
64. Chondrogianni N., Petropoulos I., Franceschi C., Friguet B., Gonos E.S. Fibroblast cultures from healthy centenarians have an active proteasome. Exp Gerontol 2000, 35:721-728.
65. Sohal R.S., Ku H.H., Agarwal S., Forster M.J., Lal H. Oxidative damage, mitochondrial oxidant generation and antioxidant defenses during aging and in response to food restriction in the mouse. Mech Ageing Dev 1994, 74:121-133.
66. Rao G., Xia E., Nadakavukaren M.J., Richardson A. Effect of dietary restriction on the age-dependent changes in the expression of antioxidant enzymes in rat liver. JNutr 1990, 120:602-609.
67. Radák Z., Takahashi R., Kumiyama A., Nakamoto H., Ohno H., Ookawara T., et al. Effect of aging and late onset dietary restriction on antioxidant enzymes and proteasome activities, and protein carbonylation of rat skeletal muscle and tendon. Exp Gerontol 2002, 37:1423-1430.
68. Wohlgemuth S.E., Seo A.Y., Marzetti E., Lees H.A., Leeuwenburgh C. Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp Gerontol 2010, 45:138-148.
69. Dubey A., Forster M.J., Lal H., Sohal R.S. Effect of age and caloric intake on protein oxidation in different brain regions and on behavioral functions of the mouse. Arch Biochem Biophys 1996, 333:189-197.
70. Weindruch R., Walford R.L., Fligiel S., Guthrie D. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. JNutr 1986, 116:641-654.
71. Mattison J.A., Roth G.S., Beasley T.M., Tilmont E.M., Handy A.M., Herbert R.L., et al. Impact of caloric restriction on health and survival in rhesus monkeys from the NIA study. Nature 2012, 489:318-321.
72. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
73. Bodkin N.L., Alexander T.M., Ortmeyer H.K., Johnson E., Hansen B.C. Mortality and morbidity in laboratory-maintained Rhesus monkeys and effects of long-term dietary restriction. JGerontol A Biol Sci Med Sci 2003, 58:212-219.
74. Omodei D., Fontana L. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett 2011, 585:1537-1542.
75. Kagawa Y. Impact of westernization on the nutrition of Japanese: changes in physique, cancer, longevity and centenarians. Prev Med 1978, 7:205-217.
76. Meyer T.E., Kovacs S.J., Ehsani A.A., Klein S., Holloszy J.O., Fontana L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. JAm Coll Cardiol 2006, 47:398-402.
77. Fontana L., Meyer T.E., Klein S., Holloszy J.O. Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc Natl Acad Sci U S A 2004, 101:6659-6663.
78. Friedlander A.L., Braun B., Pollack M., MacDonald J.R., Fulco C.S., Muza S.R., et al. Three weeks of caloric restriction alters protein metabolism in normal-weight, young men. Am J Physiol Endocrinol Metab 2005, 289:E446-E455.
79. Karakelides H., Irving B.A., Short K.R., O'Brien P., Nair K.S. Age, obesity, and sex effects on insulin sensitivity and skeletal muscle mitochondrial function. Diabetes 2010, 59:89-97.
80. Jaleel A., Henderson G., Madden B., Klaus K., Morse D., Gopala S., et al. Increased oxidative damage to de novo synthesized ApoA-1 in untreated type 1 diabetic patients - a novel method to identify the relative age of proteins. Diabetologia 2010, 53:1282.
81. Park S., Lee J., Kang D.Y., Rhee C.W., Park B.J. Indoor physical activity reduces all-cause and cardiovascular disease mortality among elderly women. JPrev Med Public Health=Yebang Uihakhoe Chi 2012, 45:21-28.
82. Lin Y.P., Huang Y.H., Lu F.H., Wu J.S., Chang C.J., Yang Y.C. Non-leisure time physical activity is an independent predictor of longevity for a Taiwanese elderly population: an eight-year follow-up study. BMC Public Health 2011, 11:428.
83. Ueshima K., Ishikawa-Takata K., Yorifuji T., Suzuki E., Kashima S., Takao S., et al. Physical activity and mortality risk in the Japanese elderly: a cohort study. Am J Prev Med 2010, 38:410-418.
84. Chakravarty E.F., Hubert H.B., Lingala V.B., Fries J.F. Reduced disability and mortality among aging runners: a 21-year longitudinal study. Arch Intern Med 2008, 168:1638-1646.
85. Stessman J., Hammerman-Rozenberg R., Cohen A., Ein-Mor E., Jacobs J.M. Physical activity, function, and longevity among the very old. Arch Intern Med 2009, 169:1476-1483.
86. Radák Z., Kaneko T., Tahara S., Nakamoto H., Ohno H., Sasvári M., et al. The effect of exercise training on oxidative damage of lipids, proteins, and DNA in rat skeletal muscle: evidence for beneficial outcomes. Free Radic Biol Med 1999, 27:69-74.
87. Goto S., Naito H., Kaneko T., Chung H.Y., Radak Z. Hormetic effects of regular exercise in aging: correlation with oxidative stress. Appl Physiol Nutr Metab 2007, 32:948-953.
88. Radák Z., Kaneko T., Tahara S., Nakamoto H., Pucsok J., Sasvári M., et al. Regular exercise improves cognitive function and decreases oxidative damage in rat brain. Neurochem Int 2001, 38:17-23.
89. Goto S., Takahashi R., Kumiyama A.A., Radak Z., Hayashi T., Takenouchi M., et al. Implications of protein degradation in aging. Ann N Y Acad Sci 2001, 928:54-64.
90. Short K.R., Vittone J.L., Bigelow M.L., Proctor D.N., Rizza R.A., Coenen-Schimke J.M., et al. Impact of aerobic exercise training on age-related changes in insulin sensitivity and muscle oxidative capacity. Diabetes 2003, 52:1888-1896.
91. Lanza I.R., Short D.K., Short K.R., Raghavakaimal S., Basu R., Joyner M.J., et al. Endurance exercise as a countermeasure for aging. Diabetes 2008, 57:2933-2942.
92. Kumar V., Atherton P., Smith K., Rennie M.J. Human muscle protein synthesis and breakdown during and after exercise. JAppl Physiol 2009, 106:2026-2039.
93. Short K.R., Vittone J.L., Bigelow M.L., Proctor D.N., Nair K.S. Age and aerobic exercise training effects on whole body and muscle protein metabolism. Am J Physiol Endocrinol Metab 2004, 286:E92-E101.
94. Balagopal P., Schimke J.C., Ades P., Adey D., Nair K.S. Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metab 2001, 280:E203-E208.
95. Charlton M., Nair K.S. Protein metabolism in insulin-dependent diabetes mellitus. JNutr 1998, 128:S323-S327.